• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
RMS
Click for more information
0.91% $2.18

RAMELIUS RESOURCES LIMITED - Corporate Spotlight

Market Cap $2.502B  ! watchlist Created with Sketch. Add to my watchlist
Metals & Mining Gold

Ramelius Resources Limited is an Australia-based mid-tier gold mining company. The... Ramelius Resources Limited is an Australia-based mid-tier gold mining company. The Company owns and operates Edna May Gold Mine, Marda Gold Mine (North Yilgarn), Mt Magnet Gold Mine, Penny Gold Mine, Symes Gold Mine, Tampia Gold Mine (Narembeen). The Edna May deposit is located within the Westonia Greenstone Belt, within the Southern Cross Province of Western Australia’s Archaean Yilgarn Craton. The Mt Magnet gold project is located immediately adjacent to the town of Mt Magnet, 500 kilometers (km) north-east of Perth in the Murchison Goldfield of the Western Australian Yilgarn Craton. Its sub projects include Eridanus (Mt Magnet), Hill 60 (Mt Magnet), and Shannon (Mt Magnet). The Penny Gold Mine is located approximately 150km south-east of the Company’s Mt Magnet mining and processing operations and approximately 550km north-east of Perth in Western Australia. The Roe Gold Project is located between two operating gold mines 100km east of Kalgoorlie, Western Australia.More

No Corporate Spotlight currently available.

(20min delay)
Last
$2.18 		Change
-0.020(0.91%) 		Mkt cap ! $2.502B
Open High Low Value Volume
$2.17 $2.18 $2.13 $6.695M 3.089M

Buyers (Bids)

No. Vol. Price($)
4 20852 $2.17
 

Sellers (Offers)

Price($) Vol. No.
$2.19 86374 7
View Market Depth
Last trade - 16.10pm 01/10/2024 (20 minute delay) ?
Last
$2.18 		  Change
-0.020 ( 0.69 %)
Open High Low Volume
$2.16 $2.18 $2.13 964500
Last updated 15.59pm 01/10/2024 ?
RMS (ASX) Chart

Top Stories

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Coda Minerals (ASX:COD) CEO, Chris Stevens, joins The Market Online to discuss the company's current rights issue, and how the capital from this raise will be used to further its copper exploration in South Australia. In addition, Chris talks through the journey the company has taken over the last few years since listing until now.
Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals Actinogen Medical is developing a promising oral treatment for Alzheimer's and depression and is accelerating clinical trials with new capital.
Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger Recce Pharmaceuticals (ASX:RCE) has been on a tear this year. It's developing anti-infective, R327, with clinical results across Diabetic Foot Infection, Acute Bacterial Skin & Skin Structure Infection, and, Urosepsis/UTIs which point to a potential commercial value proposition. It also has a recent key relationship in Indonesia.
Iress runs 'hot' for Wealth Within's stock tips Financial services software play Iress (ASX:IRE) is the HotCopper Hot Stock tip this week from Wealth Within's chief analyst Dale Gillham and senior analyst Fil Tortevski.
Failure to report prompts ASX to impose multiple company suspensions The ASX today told more than 20 companies across many sectors that it would be imposing suspensions on them
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.